GCL
ARRY

Glazer Capital LLC’s Array Biopharma Inc ARRY Stock Holding History

Glazer Capital LLC’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-296,000
Closed -$13.7M – 224
2019
Q2 		$13.7M Buy
+296,000
New +$8.31M 1.59% 12

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Glazer Capital LLC's ARRY Position: Q3 2019 in Review

Glazer Capital LLC sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 296,000 shares — an estimated $13.7M sold.

Glazer Capital LLC first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $13.7M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Glazer Capital LLC reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Glazer Capital LLC sold 296,000 Array Biopharma Inc shares in Q3 2019, an estimated $13.7M.
  • Glazer Capital LLC first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Glazer Capital LLC's Array Biopharma Inc position peaked at $13.7M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Glazer Capital LLC's 13F filing for Q3 2019, filed 14 Nov 2019.